Roles of Tissue Inhibitor of Metalloproteinase-1 in Severe Asthma.
作者信息
Kim Sang-Heon
机构信息
Department of Internal Medicine, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea.
出版信息
Allergy Asthma Immunol Res. 2023 Jul;15(4):416-418. doi: 10.4168/aair.2023.15.4.416.
Abstract
摘要
相似文献
1
Roles of Tissue Inhibitor of Metalloproteinase-1 in Severe Asthma.基质金属蛋白酶-1组织抑制剂在重症哮喘中的作用
Allergy Asthma Immunol Res. 2023 Jul;15(4):416-418. doi: 10.4168/aair.2023.15.4.416.
2
Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma.血清基质金属蛋白酶-9与金属蛋白酶组织抑制因子-1的比值与中重度哮喘的类固醇反应性相关。
Am J Respir Crit Care Med. 1999 Feb;159(2):596-602. doi: 10.1164/ajrccm.159.2.9802045.
3
Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma.基质金属蛋白酶的抑制可预防哮喘小鼠模型中变应原诱导的气道炎症。
J Immunol. 1999 Apr 1;162(7):4212-9.
4
Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma.急性哮喘患者痰液中基质金属蛋白酶-9与金属蛋白酶组织抑制剂-1的比值
J Allergy Clin Immunol. 2000 May;105(5):900-5. doi: 10.1067/mai.2000.105316.
5
Cigarette smoke alters tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 levels in the basolateral secretions of human asthmatic bronchial epithelium in vitro.香烟烟雾在体外改变人哮喘支气管上皮细胞基底外侧分泌物中金属蛋白酶组织抑制剂1和基质金属蛋白酶9的水平。
J Investig Med. 2010 Jun;58(5):725-9. doi: 10.231/JIM.0b013e3181db874e.
6
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD.通过痰液和高分辨率计算机断层扫描对哮喘和慢性阻塞性肺疾病患者气道重塑的评估
Eur Respir J. 2004 Dec;24(6):910-7. doi: 10.1183/09031936.04.00032603.
7
Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma.甲苯二异氰酸酯诱导哮喘中基质金属蛋白酶-9与金属蛋白酶组织抑制剂-1之间的失衡
Clin Exp Allergy. 2004 Feb;34(2):276-84. doi: 10.1111/j.1365-2222.2004.01849.x.
8
[The effect of melatonin on the regulation of collagen accumulation and matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA and protein in a murine model of chronic asthma].[褪黑素对慢性哮喘小鼠模型中胶原蛋白积累、基质金属蛋白酶-9及基质金属蛋白酶组织抑制因子-1的mRNA和蛋白表达调控的影响]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jul;30(7):527-32.
9
Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.病情稳定的哮喘患儿气道基质金属蛋白酶-9及基质金属蛋白酶-9/金属蛋白酶组织抑制因子-1的比值降低。
Clin Exp Allergy. 2005 Sep;35(9):1168-74. doi: 10.1111/j.1365-2222.2005.02326.x.
10
[Effects of Fritillariae Cirrhosae Bulbus on MMP-2,MMP-9 and TIMP-1 in murine asthma model].[川贝母对小鼠哮喘模型中基质金属蛋白酶-2、基质金属蛋白酶-9和金属蛋白酶组织抑制因子-1的影响]
Zhongguo Zhong Yao Za Zhi. 2017 Nov;42(21):4180-4186. doi: 10.19540/j.cnki.cjcmm.20170928.018.
本文引用的文献
1
Tissue Inhibitor of Metalloproteinase-1 Enhances Eosinophilic Airway Inflammation in Severe Asthma.基质金属蛋白酶-1组织抑制剂加重重度哮喘患者的嗜酸性气道炎症
Allergy Asthma Immunol Res. 2023 Jul;15(4):451-472. doi: 10.4168/aair.2023.15.4.451. Epub 2023 Feb 28.
2
Recent insights in the role of biomarkers in severe asthma management.生物标志物在重度哮喘管理中作用的最新见解。
Front Med (Lausanne). 2022 Sep 26;9:992565. doi: 10.3389/fmed.2022.992565. eCollection 2022.
3
Cut loose TIMP-1: an emerging cytokine in inflammation.释放基质金属蛋白酶组织抑制因子-1：一种在炎症中崭露头角的细胞因子。
Trends Cell Biol. 2023 May;33(5):413-426. doi: 10.1016/j.tcb.2022.08.005. Epub 2022 Sep 23.
4
TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer.TIMP1 触发胰腺癌中的中性粒细胞胞外诱捕网形成。
Cancer Res. 2021 Jul 1;81(13):3568-3579. doi: 10.1158/0008-5472.CAN-20-4125. Epub 2021 May 3.
5
Biomarkers for Severe Asthma: Lessons From Longitudinal Cohort Studies.重症哮喘的生物标志物：纵向队列研究的经验教训
Allergy Asthma Immunol Res. 2021 May;13(3):375-389. doi: 10.4168/aair.2021.13.3.375.
6
Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma.关于生物制剂治疗重度难治性2型哮喘的实用临床观点
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3363-3370. doi: 10.1016/j.jaip.2020.06.048. Epub 2020 Jul 13.
7
Critical Points on the Use of Biologicals in Allergic Diseases and Asthma.过敏性疾病和哮喘中生物制剂的使用要点
Allergy Asthma Immunol Res. 2020 Jan;12(1):24-41. doi: 10.4168/aair.2020.12.1.24.
8
Increased Ratio of Matrix Metalloproteinase-9 (MMP-9)/Tissue Inhibitor Metalloproteinase-1 from Alveolar Macrophages in Chronic Asthma with a Fast Decline in FEV at 5-Year Follow-up.在慢性哮喘患者中，肺泡巨噬细胞基质金属蛋白酶-9（MMP-9）/金属蛋白酶组织抑制因子-1比例升高，5年随访时FEV快速下降。
J Clin Med. 2019 Sep 12;8(9):1451. doi: 10.3390/jcm8091451.
9
Asthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?哮喘生物标志物：它们是否让精准医学更接近临床实践？
Allergy Asthma Immunol Res. 2017 Nov;9(6):466-476. doi: 10.4168/aair.2017.9.6.466.
10
Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma.低痰液 MMP-9/TIMP 比值与哮喘吸烟者气道狭窄有关。
Eur Respir J. 2014 Oct;44(4):895-904. doi: 10.1183/09031936.00047014. Epub 2014 Jul 3.
Zotero 插件